| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/28/1997 | EP0775478A1 Combinations of active ingredients based on partial glycerides and dialkylsubstituted acetic acids efficient against bacteria, mycoses and viruses |
| 05/28/1997 | EP0775339A1 Current-to-pressure transducer with selectable, adjustable input filter |
| 05/28/1997 | EP0775213A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 05/28/1997 | EP0775209A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 05/28/1997 | EP0775204A1 Antitumor antisense oligonucleotides |
| 05/28/1997 | EP0775200A1 Recombinant kat enzyme and process for its preparation |
| 05/28/1997 | EP0775197A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor |
| 05/28/1997 | EP0775157A1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof |
| 05/28/1997 | EP0775156A1 Pharmaceutical compositions containing estra-1,3,5(10)-triene derivatives |
| 05/28/1997 | EP0775155A1 Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceutical compositions containing them |
| 05/28/1997 | EP0775154A1 Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function |
| 05/28/1997 | EP0775151A2 Sialic acid/fucose based medicaments |
| 05/28/1997 | EP0775150A1 Endotoxin reduction or removal process |
| 05/28/1997 | EP0775145A1 Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
| 05/28/1997 | EP0775144A1 6 beta-substituted penicillanic acids as beta-lactamase inhibitors |
| 05/28/1997 | EP0775143A1 New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 05/28/1997 | EP0775142A1 Substituted o6 -benzylguanines and 6(4)-benzyloxypyrimidines |
| 05/28/1997 | EP0775141A1 Phenyl xanthine derivatives |
| 05/28/1997 | EP0775140A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents |
| 05/28/1997 | EP0775138A1 TETRAHYDROPYRIDINYLMETHYL DERIVATIVES OF PYRROLO 2,3-b]PYRIDINE |
| 05/28/1997 | EP0775135A1 N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics |
| 05/28/1997 | EP0775132A1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 05/28/1997 | EP0775131A2 Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects |
| 05/28/1997 | EP0775130A1 Method for the preparation of (+/-)-calanolide a and intermediates thereof |
| 05/28/1997 | EP0775129A1 3-benzoyl benzofuran derivatives as thyroid hormone antagonists |
| 05/28/1997 | EP0775126A1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 05/28/1997 | EP0775122A1 Crystalline form of an antifungal azole |
| 05/28/1997 | EP0775120A1 Novel pyrimidine derivatives and processes for the preparation thereof |
| 05/28/1997 | EP0775118A1 Benzimidazole derivatives having dopaminergic activity |
| 05/28/1997 | EP0775115A1 Dimeric arylisoquinoline alkaloids and synthesis methods thereof |
| 05/28/1997 | EP0775114A1 Process for making antimicrobial compounds |
| 05/28/1997 | EP0775113A1 N-substituted azabicycloheptane derivatives useful as neuroleptics |
| 05/28/1997 | EP0775111A1 Stable vitamin a |
| 05/28/1997 | EP0775110A1 Arylthio compounds as antibacterial and antiviral agents |
| 05/28/1997 | EP0775103A1 Retinoic acid x-receptor ligands |
| 05/28/1997 | EP0774974A1 Novel vaccine adjuvant and vaccine |
| 05/28/1997 | EP0774969A1 Hiv protease inhibitor combination |
| 05/28/1997 | EP0774968A1 Method of preventing and treating ophthalmic inflammation and/or wound |
| 05/28/1997 | EP0774967A1 Use of quinone and hydroquinone derivatives for the teatment of cachexia |
| 05/28/1997 | EP0774965A1 Phenoxyphenylacetic acid derivatives |
| 05/28/1997 | EP0774964A1 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 05/28/1997 | EP0774963A1 Pharmaceutically stable oxaliplatinum preparation |
| 05/28/1997 | EP0774962A1 Use of dha as a pharmaceutical composition |
| 05/28/1997 | EP0774961A1 Use of selegilin in the treatment of epilectic conditions |
| 05/28/1997 | EP0774958A1 Vesicle formulation |
| 05/28/1997 | EP0774956A1 PROCESS FOR PREPARING BECLOMETHASONE DIPROPIONATE FREON$m(3) CLATHRATE |
| 05/28/1997 | EP0774949A1 Denture adhesive |
| 05/28/1997 | EP0774902A1 Antisense and triplex therapeutic agents and methods |
| 05/28/1997 | EP0717620A4 Substituted 2-aminotetralins |
| 05/28/1997 | EP0710107A4 N,n,n-trimethylsphingosine derivatives |
| 05/28/1997 | EP0708775B1 TRICYCLIC INHIBITORS OF THE GPII b III a RECEPTOR |
| 05/28/1997 | EP0693927A4 Method for treatment of menopausal and premenstrual symptoms |
| 05/28/1997 | EP0671918B1 Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections |
| 05/28/1997 | EP0668851B1 A novel arylpropionic derivative, a process for the preparation and the use thereof as an analgesic agent |
| 05/28/1997 | EP0667850B1 Tartronic acids, their acetalic ethers and o-esters |
| 05/28/1997 | EP0660822B1 Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents |
| 05/28/1997 | EP0652884B1 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity |
| 05/28/1997 | EP0641330A4 Gaba and l-glutamic acid analogs for antiseizure treatment. |
| 05/28/1997 | EP0581904B1 Method of inhibiting fibrosis |
| 05/28/1997 | EP0579614B1 Imidazoacridines and their antineoplastic use |
| 05/28/1997 | EP0569380B1 Acridine derivatives |
| 05/28/1997 | EP0546092B1 Therapeutic ribozyme compositions |
| 05/28/1997 | EP0526511B1 Method and composition for treatment of central nervous systems disease states associated with abnormal amyloid beta protein |
| 05/28/1997 | EP0468054B1 Benzenesulfonamide derivative |
| 05/28/1997 | DE19545251A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments |
| 05/28/1997 | DE19543989A1 Hair bleaching composition preparation |
| 05/28/1997 | DE19543554A1 Identifizierung von Antigenen aus post-infektiösen Nematoden zur Entwicklung neuer Anthelmintika und Vakzinen Identification of antigens from post-infective nematodes to develop new vaccines and anthelmintics |
| 05/28/1997 | DE19543553A1 VP-Antigene des JC-Virus VP-antigens of the JC virus |
| 05/28/1997 | DE19543476A1 Treatment of skull-brain trauma with aminomethyl-chroman compounds |
| 05/28/1997 | CN1150804A Fibroblast growth factor-10 |
| 05/28/1997 | CN1150803A Pyrazolo and pyrrolopyridines |
| 05/28/1997 | CN1150802A Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 05/28/1997 | CN1150799A Benzoheterocyclic derivatives |
| 05/28/1997 | CN1150798A 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption |
| 05/28/1997 | CN1150760A Methods for inducing T cell tolerance to tissue or organ graft |
| 05/28/1997 | CN1150759A Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents |
| 05/28/1997 | CN1150758A Process for preparation of acanthoic acid and pharmaceutical composition comprising same |
| 05/28/1997 | CN1150754A Human osteoclast-derived cathepsin |
| 05/28/1997 | CN1150589A New sulfuric acid esters of sugar alcohols |
| 05/28/1997 | CN1150588A Method for preparing N-(4-phenelyl)-2-hydroxybenzamide drug composition and its use |
| 05/28/1997 | CN1150548A Drug for curing leukopenia and radiation damage |
| 05/28/1997 | CN1150547A External use emulsion for curing burn |
| 05/28/1997 | CN1150541A Spray containing diclofenac sodium |
| 05/28/1997 | CN1150540A Health-care food for preventing radiation and angiocardiopathy |
| 05/28/1997 | CN1150522A Health care candy for watching TV |
| 05/28/1997 | CN1035005C Process for producing 6-(3-dimethylaminopropionyl) forskolin |
| 05/28/1997 | CN1035001C Substituted phenyl phenol leukotriene antagonists |
| 05/27/1997 | US5633400 Process for the preparation of biphenyl derivatives |
| 05/27/1997 | US5633395 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/27/1997 | US5633393 Estradiol derivative-alkylating agent conjugate with reduced hormonal activity, process for preparing the same, compounds useful for the preparation thereof, and growth inhibiting compositon containing the conjugate or estradiol derivative. |
| 05/27/1997 | US5633382 Histamine H3 -receptor antagonists and therapeutic uses thereof |
| 05/27/1997 | US5633379 3-heteroaliphatyl- and 3-hetero(aryl)aliphatyl-2(1H)-quinolone derivatives |
| 05/27/1997 | US5633371 Enzyme inhibitors; treatment of depression and parkinson*s disease |
| 05/27/1997 | US5633369 Immunostimulants |
| 05/27/1997 | US5633366 Chemical intermediates for 3'-azido-3'-deoxythymidine |
| 05/27/1997 | US5633351 Targeting protein-diagnostic/therapeutic agent conjugates having Schiff base linkages |
| 05/27/1997 | US5633344 Crosslinked polymeric ammonium salts |
| 05/27/1997 | US5633288 Expectorant |
| 05/27/1997 | US5633287 N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| 05/27/1997 | US5633285 Cytoprotective wound healing compositions and methods for preparing and using same |